John P Gibbs, Ii

Title: John P. Gibbs, II: Innovator in Biopharmaceuticals

Introduction

John P. Gibbs, II is an inventor based in Mercer Island, WA (US). He is currently associated with Amgen Inc., a leading biopharmaceutical company. Although he has not yet been granted any patents, his work focuses on significant advancements in the treatment of various medical conditions.

Latest Patent Applications

John P. Gibbs, II has been involved in several notable patent applications. One of his latest applications is titled "Methods for Treating Psoriasis Using an Anti-IL-23 Antibody." This invention relates to products and methods for treating psoriasis, specifically through antibodies that inhibit native human IL-23 while sparing IL-12. The application describes a Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of an anti-IL-23 antibody (AMG 139) in healthy subjects and subjects with moderate to severe psoriasis.

Another significant application is "Methods of Treating or Preventing Cholesterol Related Disorders." This invention focuses on methods for treating or preventing cholesterol-related disorders, such as hypercholesterolemia, hyperlipidemia, or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). The application also describes formulations and methods of producing these formulations.

Conclusion

John P. Gibbs, II is making strides in the field of biopharmaceuticals through his innovative patent applications. His work has the potential to significantly impact the treatment of psoriasis and cholesterol-related disorders.